Teoh Leanne, Löffler Christin, Mun Michelle, Agnihotry Anirudha, Kaur Harpinder, Born Karen, Thompson Wendy
University of Melbourne, Carlton, Victoria, Australia.
Universitätsmedizin Rostock, Rostock, Germany.
Community Dent Oral Epidemiol. 2025 Jun;53(3):245-255. doi: 10.1111/cdoe.13009. Epub 2024 Oct 14.
Antimicrobial resistance is a significant threat to global health. Antimicrobial stewardship is reducing inappropriate antimicrobial prescribing to counter it. Dentists prescribe ~10% of all antibiotics worldwide, yet up to 90% of antibiotic prescriptions by dentists are inappropriate. The aim of this systematic review was to update a 2017 review evaluating the effects of antibiotic stewardship interventions in dental settings, using the international consensus on core outcomes for dental antibiotic stewardship.
Systematic database searches were undertaken in April 2023, of the: Cochrane Oral Health Group Trials Register, Cochrane Central Register of Controlled Trials, MEDLINE via OVID, EMBASE via OVID, Dentistry and Oral Sciences Source, the US National Institutes of Health Trials Register, the World Health Organisation International Clinical Trials Registry Platform and the ISRCTN registry databases. Randomised controlled trials (or non-randomised studies with clearly reported mechanism of group formation and inclusion criteria) of interventions to optimise and/or reduce dental antibiotic prescribing were eligible for inclusion. Two authors independently screened for eligible studies. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool, certainty of evidence assessed using GRADE. Meta-analysis was planned whether the results of studies reported similar outcomes, otherwise narrative synthesis was undertaken.
Three eligible studies randomising 2148 participants were included. The interventions were combinations of education, audit and feedback and written behaviour change messages, guideline summary, practice visits and patient leaflets. None of the control groups received an intervention. All three included studies measured the quantity of antibiotics prescribed and two measured the appropriateness of prescribing. None measured patient-reported or adverse outcomes. Two included studies were assessed as 'high risk' and one with 'low risk' of bias. There was high-certainty evidence that audit and personalised feedback with individualised behaviour change messages can be effective. Evidence for in-person education was low-certainty. Guideline dissemination alone was ineffective at improving antibiotic prescribing. Due to different outcomes reported, meta-analysis was inappropriate.
Although various dental antibiotic stewardship interventions have been reported in the literature, only three have been evaluated using a randomised design, of which only one provided high certainty evidence. To strengthen the body of evidence, well-powered, robust, randomised controlled trials are required, with adequate follow-up, reporting the internationally-agreed core outcomes and including a parallel process evaluation is recommended.
PROSPERO (CRD42023411476).
抗菌药物耐药性是对全球健康的重大威胁。抗菌药物管理旨在减少不适当的抗菌药物处方以应对这一问题。牙医开具的抗生素占全球所有抗生素处方的约10%,然而牙医开具的抗生素处方中高达90%是不适当的。本系统评价的目的是更新2017年的一项评价,使用牙科抗生素管理核心结局的国际共识,评估牙科环境中抗生素管理干预措施的效果。
2023年4月对以下数据库进行了系统检索:Cochrane口腔健康组试验注册库、Cochrane对照试验中心注册库、通过OVID检索的MEDLINE、通过OVID检索的EMBASE、牙科与口腔科学资源库、美国国立卫生研究院试验注册库、世界卫生组织国际临床试验注册平台和ISRCTN注册数据库。优化和/或减少牙科抗生素处方的干预措施的随机对照试验(或具有明确报告的分组机制和纳入标准的非随机研究)符合纳入条件。两名作者独立筛选符合条件的研究。使用Cochrane偏倚风险2工具评估偏倚风险,使用GRADE评估证据的确定性。如果研究结果报告了相似的结局,则计划进行Meta分析,否则进行叙述性综合分析。
纳入了三项随机分配2148名参与者的符合条件的研究。干预措施包括教育、审核与反馈以及书面行为改变信息、指南摘要、实践访问和患者传单的组合。对照组均未接受干预。所有三项纳入研究均测量了开具的抗生素数量,两项研究测量了处方的适当性。没有一项研究测量患者报告的结局或不良结局。两项纳入研究被评估为“高风险”偏倚,一项为“低风险”偏倚。有高确定性证据表明审核和带有个性化行为改变信息的个性化反馈可能有效。面对面教育的证据确定性低。仅传播指南在改善抗生素处方方面无效。由于报告的结局不同,Meta分析不适用。
尽管文献中报道了各种牙科抗生素管理干预措施,但只有三项使用随机设计进行了评估,其中只有一项提供了高确定性证据。为了加强证据基础,建议进行有足够效力、稳健的随机对照试验,进行充分的随访,报告国际商定的核心结局,并包括平行的过程评估。
PROSPERO(CRD42023411476)。